CAPTRUST Financial Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
12,421
+4,378
+54% +$476K ﹤0.01% 1353
2026
Q1
$743K Buy
8,043
+5,786
+256% +$581K ﹤0.01% 1779
2025
Q4
$231K Buy
+2,257
New +$202K ﹤0.01% 2432
2022
Q3
Sell
-1,087
Closed -$44K 2844
2022
Q2
$44K Buy
1,087
+271
+33% +$13.4K ﹤0.01% 2845
2022
Q1
$54K Sell
816
-1,308
-62% -$89.5K ﹤0.01% 2728
2021
Q4
$212K Buy
2,124
+117
+6% +$12.1K ﹤0.01% 1600
2021
Q3
$251K Buy
2,007
+179
+10% +$21.3K ﹤0.01% 1403
2021
Q2
$227K Sell
1,828
-716
-28% -$96.3K ﹤0.01% 1426
2021
Q1
$388K Buy
2,544
+1,420
+126% +$215K ﹤0.01% 1072
2020
Q4
$145K Sell
1,124
-100
-8% -$11.5K ﹤0.01% 1334
2020
Q3
$133K Hold
1,224
﹤0.01% 1214
2020
Q2
$102K Sell
1,224
-149
-11% -$12K ﹤0.01% 1341
2020
Q1
$92K Buy
+1,373
New +$105K ﹤0.01% 1159
2019
Q4
Sell
-50
Closed -$3K 1322
2019
Q3
$3K Hold
50
﹤0.01% 1734
2019
Q2
$4K Sell
50
-100
-67% -$7.64K ﹤0.01% 1691
2019
Q1
$12K Buy
+150
New +$8.32K ﹤0.01% 1341

Other funds holding GH

CAPTRUST Financial Advisors's GH Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Guardant Health (GH) stake by 54% in Q2 2026, buying an estimated $476K and bringing the position to 12,421 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1353.

CAPTRUST Financial Advisors first reported a position in GH in Q1 2019 and has held it in 16 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • CAPTRUST Financial Advisors held 12,421 shares of Guardant Health worth $1.86M as of Q2 2026.
  • CAPTRUST Financial Advisors bought 4,378 Guardant Health shares in Q2 2026, an estimated $476K.
  • Guardant Health made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1353 holding.
  • CAPTRUST Financial Advisors first reported a position in Guardant Health in Q1 2019 and has held it in 16 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.